The contract is a Federal Supply Schedule (FSS) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Eyevance Pharmaceuticals LLC, a foreign-owned for-profit manufacturer. The FSS contract is under Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, with a potential value of $450,000 and a period of performance through December 14, 2024.
The contract aims to procure a range of pharmaceutical and drug products from the vendor. As an FSS contract, it is a multiple award vehicle, meaning other vendors may also hold contracts under this schedule. The contract does not utilize any small business set-asides. While the specific products and services to be delivered are not enumerated, the schedule description indicates the contracted items will relate to drugs, pharmaceuticals, and hematology products. The VA, as a major healthcare provider for U.S. veterans, is the primary customer and funding agency for this contract.
Generated 3/20/24, 2:56 PM